• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 2000

View Archived Issues

Licensing opportunity from NIH: vaccinia virus vector for cancer therapy

Read More

Licensing opportunity from NIH: subunit vaccine for viral diseases

Read More

CytRx and Merck enter TranzFect agreement

Read More

Verteporfin shows promise in clinical trials for the treatment of skin cancer

Read More

MediGene to acquire NeuroVir

Read More

NeoTherapeutics to focus on higher doses of Neotrofin

Read More

Promising phase III results with Gliadel as first-line treatment of malignant glioma

Read More

Completion of Elan's acquisition of Dura announced

Read More

Genelabs Technologies and Watson enter collaboration and licensing agreement for lupus drug

Read More

Icos receives license from Stanford for novel antibiotic target

Read More

PDT with MV-6401 prevents neointimal formation following carotid artery angioplasty in rats

Read More

Selective ETA antagonism with TBC-3711 as a new approach to neonatal pulmonary hypertension

Read More

Hemodynamic effects and safety of conivaptan in advanced heart failure discussed at AHA meeting

Read More

AHA news: new MTP inhibitor markedly reduces postprandial fat absorption in humans

Read More

Phase I/II data indicate efficacy and safety of TP-10 in preventing post-CPB inflammation in infants

Read More

Acronycine analogue S-23906 confirmed as a potential development candidate for solid tumors

Read More

Trizivir anti-HIV therapy approved by FDA

Read More

Potential cellular mechanism for adverse cardiac effects of Herceptin described at AHA sessions

Read More

ALS treatment now available from Aventis in Canada

Read More

Chemokine receptor-modulating pyrrolidine derivatives described by Merck

Read More

Novel tetrahydropyridazines from Merck KGaA inhibit PDE4 and TNF

Read More

BASF presents small molecules with tyrosine kinase-inhibitory activity

Read More

European Commission grants orphan drug status to Mylotarg for treatment of AML

Read More

NOS inhibitors derived from lipoic acid described in recent patent by SCRAS

Read More

Series of selective Tgamma9delta2 lymphocyte inhibitors emerges from joint U.S.-French R&D

Read More

Promising first clinical data on NESP in anemic cancer patients presented at ESMO

Read More

SB's new ET receptor antagonists covered by U.S. patent

Read More

Naeja describes preparation, activity and use of new cathepsin inhibitors

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe